Many medical protocols and standards were designed with a narrow patient cohort in mind: white men. Through research, we are finding that men and women often report significantly different liver enzyme levels. Liver enzymes serve as a threshold for additional testing (and contribute to diagnosis of many diseases as an affordable blood biomarker). Thus, it is important that we consider refining these thresholds to make them relevant to more people. This publication suggests gender-specific screening thresholds for fibroscan to better gage liver scarring and steatosis (fatty build up).
Intellectual Property Owner